In part 1 of this Exclusive Interview, Dr. Emily Seto talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the focus on mobile technology in the area of healthcare management.
Emily Seto, PhD, PEM is an Assistant Professor and Lead for the health informatics programs at the Institute of Health Policy, Management and Evaluation at the University of Toronto.
Transcript of this video segment:
Steve Freed: This is Steve Freed with Diabetes in Control, and we are here in San Diego for the American Diabetes Association 77th Scientific Sessions, and we have some really great interviews with some of the top endocrinologists from all across the globe. We have a special guest with us today, Emily Seto, PhD, PEM. Can you start off by telling us a little bit about yourself?
Emily Seto: Sure. I am an engineer by background, actually and right now I work at the University of Toronto and I am the lead for the health informatics programs there. I’ve also been doing research in the field of mobile health for the past 14 years or so and looking at how do we improve chronic disease management through use of these types of technologies.
Steve Freed: I know you’re presenting here. What is the title of your presentation?
Emily Seto: So, I was looking at the successes and failures of mHealth in chronic disease management.
Steve Freed: Can you explain to us what mHealth is?
Emily Seto: So mHealth is mobile health. It is an emerging field — kind of a subset of eHealth, so basically looking at how mobile technologies can be used in healthcare. So, you’re talking about health apps such as those wearables like Fitbit and things like that.
Steve Freed: So there are a lot of diabetes apps out there. We try to keep a list and it changes on a daily basis. Most people put together apps that have no history behind them. So, what makes the mHealth app different?
Emily Seto: So mHealth is the category of health apps, so in terms of what we kind of do in our lab is that we’ve created a number of different types of health apps that are geared towards chronic disease management. We do it in collaboration with patients and a lot of clinicians and we get the feedback through iterative usability design and really understanding the needs of the patients. We also provide evidence; we do trials to try to figure out whether or not it’s actually helping patients and also the providers, and if it’s actually saving the healthcare system any money.